Skip to main content

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

RNAC holding history

Cartesian Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RNAC overviewAll 13F holders of RNACFull Q2 2026 holdings

Shares (Q2 2026)
20,300
Value
$211.5K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of RNAC by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202620,300$211.5K<0.1%−47,000−69.8%ReducedHolders
Q1 202667,300$413.9K<0.1%+26,200+63.7%AddedHolders
Q4 202541,100$296.3K<0.1%+41,100NewHolders
Q3 20250$00.0%−19,500−100.0%Sold outHolders
Q2 202519,500$202.6K<0.1%+19,500NewHolders
Q1 20250$00.0%−13,800−100.0%Sold outHolders
Q4 202413,800$247.2K<0.1%+13,800NewHolders
Q3 20240$00.0%−17,052−100.0%Sold outHolders
Q2 202417,052$460.6K<0.1%−536,548−96.9%ReducedHolders
Q1 2024553,600$360.0K<0.1%+35,800+6.9%AddedHolders
Q4 2023517,800$357.0K<0.1%−208,200−28.7%ReducedHolders
Q3 2023726,000$770.0K<0.1%−276,502−27.6%ReducedHolders
Q2 20231,002,502$1.12M<0.1%−70,585−6.6%ReducedHolders
Q1 20231,073,087$1.49M<0.1%−151,768−12.4%ReducedHolders
Q4 20221,224,855$1.38M<0.1%+319,755+35.3%AddedHolders
Q3 2022905,100$1.48M<0.1%+316,716+53.8%AddedHolders
Q2 2022588,384$771.0K<0.1%−902,016−60.5%ReducedHolders
Q1 20221,490,400$1.83M<0.1%+1,014,200+213.0%AddedHolders
Q4 2021476,200$1.55M<0.1%+214,000+81.6%AddedHolders
Q3 2021262,200$1.09M<0.1%−166,051−38.8%ReducedHolders
Q2 2021428,251$1.79M<0.1%+143,751+50.5%AddedHolders
Q1 2021284,500$1.29M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.